Wealth Enhancement Advisory Services
WST icon

Wealth Enhancement Advisory Services’s West Pharmaceutical WST Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.89M Buy
14,417
+2,725
+23% +$833K 0.01% 1013
2026
Q1 		$2.98M Sell
11,692
-9,788
-46% -$2.44M 0.01% 1183
2025
Q4 		$6.03M Sell
21,480
-7,693
-26% -$2.1M 0.01% 929
2025
Q3 		$7.76M Buy
29,173
+2,621
+10% +$637K 0.01% 749
2025
Q2 		$5.9M Sell
26,552
-1,382
-5% -$295K 0.01% 833
2025
Q1 		$6.25M Sell
27,934
-2,318
-8% -$639K 0.01% 742
2024
Q4 		$9.91M Sell
30,252
-1,375
-4% -$433K 0.02% 557
2024
Q3 		$9.49M Sell
31,627
-642
-2% -$197K 0.02% 530
2024
Q2 		$10.6M Sell
32,269
-4,493
-12% -$1.59M 0.03% 475
2024
Q1 		$14.5M Sell
36,762
-303
-0.8% -$112K 0.04% 381
2023
Q4 		$13.1M Buy
37,065
+105
+0.3% +$37.2K 0.04% 375
2023
Q3 		$13.9M Buy
+36,960
New +$14.3M 0.05% 342
2022
Q4 		– Sell
-6,378
Closed -$1.59M – 376
2022
Q3 		$1.59M Buy
6,378
+2,613
+69% +$796K 0.02% 190
2022
Q2 		$1.2M Buy
+3,765
New +$1.23M 0.02% 238
2021
Q3 		– Sell
-4,099
Closed -$1.52M – 346
2021
Q2 		$1.52M Buy
4,099
+514
+14% +$170K 0.02% 154
2021
Q1 		$1.04M Buy
3,585
+141
+4% +$40.4K 0.02% 195
2020
Q4 		$1.03M Buy
+3,444
New +$966K 0.02% 164
2020
Q3 		– Sell
-6,021
Closed -$1.54M – 247
2020
Q2 		$1.54M Buy
+6,021
New +$1.18M 0.04% 141

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wealth Enhancement Advisory Services's WST Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its West Pharmaceutical (WST) stake by 23% in Q2 2026, buying an estimated $833K and bringing the position to 14,417 shares worth $4.89M. The position accounts for 0.01% of the portfolio, ranked #1013.

Wealth Enhancement Advisory Services first reported a position in WST in Q2 2020 and has held it in 18 quarters since. The position peaked at $14.5M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Wealth Enhancement Advisory Services held 14,417 shares of West Pharmaceutical worth $4.89M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 2,725 West Pharmaceutical shares in Q2 2026, an estimated $833K.
  • West Pharmaceutical made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1013 holding.
  • Wealth Enhancement Advisory Services first reported a position in West Pharmaceutical in Q2 2020 and has held it in 18 quarters since.
  • Wealth Enhancement Advisory Services's West Pharmaceutical position peaked at $14.5M in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.